BioMarin Pharmaceutical Inc.

BRSE:BM8 Stock Report

Market Cap: CHF 9.5b

BioMarin Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BRSE:BM8 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Mar 25SellCHF 443,484C. GuyerIndividual7,034CHF 63.05
12 Nov 24SellCHF 309,017C. GuyerIndividual5,278CHF 58.55

Insider Trading Volume

Insider Buying: BM8 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of BM8?
Owner TypeNumber of SharesOwnership Percentage
State or Government170,6750.089%
Individual Insiders1,478,3310.771%
General Public4,680,0782.44%
Hedge Funds10,800,0595.63%
Institutions174,646,52291.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 72.37% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.4%
BlackRock, Inc.
23,773,172CHF 1.2b1.13%0.02%
9.91%
The Vanguard Group, Inc.
19,003,212CHF 945.1m-1.9%0.02%
9.27%
PRIMECAP Management Company
17,773,281CHF 884.0m-2.29%0.81%
7.8%
Dodge & Cox
14,955,240CHF 743.8m1.42%0.28%
5.63%
Viking Global Investors LP
10,800,059CHF 537.1m2.75%1.91%
4.77%
Capital Research and Management Company
9,150,655CHF 455.1m-29.6%0.02%
4.41%
State Street Global Advisors, Inc.
8,463,090CHF 420.9m-7.12%0.02%
2.19%
Columbia Management Investment Advisers, LLC
4,207,563CHF 209.3m-6.5%0.06%
1.86%
Norges Bank Investment Management
3,569,831CHF 177.5m0%0.02%
1.83%
Elliott Management Corporation
3,500,338CHF 174.1m0%1.91%
1.79%
Geode Capital Management, LLC
3,431,253CHF 170.7m4.33%0.01%
1.43%
UBS Asset Management AG
2,749,101CHF 136.7m7.23%0.01%
0.98%
Deutsche Asset & Wealth Management
1,878,570CHF 93.4m13.4%0.03%
0.88%
Northern Trust Global Investments
1,696,864CHF 84.4m-1.63%0.01%
0.83%
Citadel Advisors LLC
1,595,058CHF 79.3m312%0.09%
0.8%
Charles Schwab Investment Management, Inc.
1,532,314CHF 76.2m7.64%0.01%
0.72%
Squarepoint OPS LLC
1,388,728CHF 69.1m100%0.19%
0.71%
BNY Asset Management
1,363,305CHF 67.8m-42.9%0.01%
0.67%
Goldman Sachs Asset Management, L.P.
1,287,352CHF 64.0m184%0.02%
0.64%
Rothschild & Cie Gestion
1,230,709CHF 61.2m0%1.11%
0.63%
AQR Capital Management, LLC
1,214,306CHF 60.4m0%0.09%
0.61%
Dimensional Fund Advisors LP
1,167,495CHF 58.1m1.26%0.01%
0.56%
Soleus Capital Management, L.P.
1,079,304CHF 53.7m7.78%4.68%
0.52%
DNB Asset Management AS
991,486CHF 49.3m-0.17%0.19%
0.52%
Palo Alto Investors LP
991,207CHF 49.3m-7.13%12.73%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/18 06:19
End of Day Share Price 2025/05/09 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioMarin Pharmaceutical Inc. is covered by 56 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jack AllenBaird
Ishan MajumdarBaptista Research
Ying HuangBarclays